These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18089806)

  • 1. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.
    Nangia-Makker P; Raz T; Tait L; Hogan V; Fridman R; Raz A
    Cancer Res; 2007 Dec; 67(24):11760-8. PubMed ID: 18089806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer.
    Nangia-Makker P; Wang Y; Raz T; Tait L; Balan V; Hogan V; Raz A
    Int J Cancer; 2010 Dec; 127(11):2530-41. PubMed ID: 20162566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.
    Nangia-Makker P; Raz T; Tait L; Shekhar MP; Li H; Balan V; Makker H; Fridman R; Maddipati K; Raz A
    Cancer Biol Ther; 2013 May; 14(5):417-27. PubMed ID: 23380593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
    Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
    Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
    Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
    BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.
    Oh J; Takahashi R; Kondo S; Mizoguchi A; Adachi E; Sasahara RM; Nishimura S; Imamura Y; Kitayama H; Alexander DB; Ide C; Horan TP; Arakawa T; Yoshida H; Nishikawa S; Itoh Y; Seiki M; Itohara S; Takahashi C; Noda M
    Cell; 2001 Dec; 107(6):789-800. PubMed ID: 11747814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
    Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
    Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
    Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
    Cancemi P; Buttacavoli M; Roz E; Feo S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
    Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
    Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage.
    Ulmer TA; Keeler V; André S; Gabius HJ; Loh L; Laferté S
    Biochim Biophys Acta; 2010 Mar; 1800(3):336-43. PubMed ID: 19665518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Bendrik C; Robertson J; Gauldie J; Dabrosin C
    Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
    Nilsson UW; Dabrosin C
    Cancer Res; 2006 May; 66(9):4789-94. PubMed ID: 16651433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
    J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
    Fry SA; Van den Steen PE; Royle L; Wormald MR; Leathem AJ; Opdenakker G; McDonnell JM; Dwek RA; Rudd PM
    Biochemistry; 2006 Dec; 45(51):15249-58. PubMed ID: 17176047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.
    Mitropoulou TN; Tzanakakis GN; Kletsas D; Kalofonos HP; Karamanos NK
    Int J Cancer; 2003 Mar; 104(2):155-60. PubMed ID: 12569569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
    Brummer O; Athar S; Riethdorf L; Löning T; Herbst H
    Virchows Arch; 1999 Dec; 435(6):566-73. PubMed ID: 10628798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
    Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
    BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.